SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2f8l'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4Y_A_TPVA501_2 (PROTEIN (HIV-1 PROTEASE))	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 8	LEU A 321 ALA A 306 GLY A 269 ILE A 289 ILE A 320	None	1.49A	1d4yB-2f8lA: undetectable	1d4yB-2f8lA: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_B_RALB600_2 (ESTROGEN RECEPTOR)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 6	LEU A 123 ASP A 191 MET A 174 LEU A 176	None	1.18A	1errB-2f8lA: undetectable	1errB-2f8lA: 22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK2_A_T44A3004_1 (SERUM ALBUMIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 7	PHE A 249 ALA A 306 LEU A 305 VAL A 303	None	0.93A	1hk2A-2f8lA: undetectable	1hk2A-2f8lA: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QAO_A_SAMA245_0 (ERMC' METHYLTRANSFERASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	GLY A 128 ASP A 156 LEU A 159 ASP A 180 PRO A 198	SAM A 400 (-3.3A) None SAM A 400 (-4.3A) SAM A 400 (-3.4A) SAM A 400 (-3.8A)	0.70A	1qaoA-2f8lA: 12.4	1qaoA-2f8lA: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SQF_A_SAMA430_1 (SUN PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	3 / 3	PRO A 125 ASP A 154 ASP A 180	None SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.78A	1sqfA-2f8lA: 11.8	1sqfA-2f8lA: 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ADM_A_SAMA500_0 (ADENINE-N6-DNA-METHY LTRANSFERASE TAQI)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 11	ALA A 126 ASP A 156 ASP A 180 PRO A 198 PHE A 226	SAM A 400 (-3.4A) None SAM A 400 (-3.4A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	0.59A	2admA-2f8lA: 19.9	2admA-2f8lA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ADM_A_SAMA500_0 (ADENINE-N6-DNA-METHY LTRANSFERASE TAQI)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 11	THR A 98 ALA A 126 ASP A 180 PRO A 198 PHE A 226	SAM A 400 (-3.8A) SAM A 400 (-3.4A) SAM A 400 (-3.4A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	1.06A	2admA-2f8lA: 19.9	2admA-2f8lA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ADM_B_SAMB500_0 (ADENINE-N6-DNA-METHY LTRANSFERASE TAQI)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 11	THR A 98 ALA A 126 ASP A 180 PRO A 198 PHE A 226	SAM A 400 (-3.8A) SAM A 400 (-3.4A) SAM A 400 (-3.4A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	1.07A	2admB-2f8lA: 20.0	2admB-2f8lA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_B_CQAB401_0 (HISTAMINE N-METHYLTRANSFERASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 7	GLY A 181 ASP A 204 TYR A 202 THR A 210	SAM A 400 (-3.6A) None None None	1.13A	2aouB-2f8lA: 13.2	2aouB-2f8lA: 23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CDQ_A_SAMA1500_0 (ASPARTOKINASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 8	ILE A 122 SER A 121 ASP A 191 LEU A 110	None	0.95A	2cdqA-2f8lA: undetectable	2cdqA-2f8lA: 22.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8L_A_SAMA400_0 (HYPOTHETICAL PROTEIN LMO1582)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	12 / 12	HIS A 95 ALA A 126 GLY A 128 ASN A 131 LEU A 132 VAL A 155 ASP A 156 LEU A 159 GLY A 181 ASP A 196 PRO A 198 PHE A 226	SAM A 400 (-4.5A) SAM A 400 (-3.4A) SAM A 400 (-3.3A) None SAM A 400 (-4.1A) SAM A 400 (-4.2A) None SAM A 400 (-4.3A) SAM A 400 (-3.6A) SAM A 400 (-3.7A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	0.04A	2f8lA-2f8lA: 56.4	2f8lA-2f8lA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8L_A_SAMA400_0 (HYPOTHETICAL PROTEIN LMO1582)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	8 / 12	HIS A 95 ALA A 126 GLY A 128 LEU A 133 VAL A 155 ASP A 156 LEU A 159 PHE A 226	SAM A 400 (-4.5A) SAM A 400 (-3.4A) SAM A 400 (-3.3A) None SAM A 400 (-4.2A) None SAM A 400 (-4.3A) SAM A 400 (-4.9A)	1.43A	2f8lA-2f8lA: 56.4	2f8lA-2f8lA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2F8L_A_SAMA400_1 (HYPOTHETICAL PROTEIN LMO1582)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 4	THR A 98 THR A 129 ASP A 154 ASP A 180	SAM A 400 (-3.8A) SAM A 400 (-2.9A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.03A	2f8lA-2f8lA: 56.4	2f8lA-2f8lA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_A_SAMA500_1 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 6	THR A 98 THR A 129 ASP A 154 ASP A 180	SAM A 400 (-3.8A) SAM A 400 (-2.9A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.41A	2okcA-2f8lA: 25.5	2okcA-2f8lA: 24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_B_SAMB500_1 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 6	THR A 98 THR A 129 ASP A 154 ASP A 180	SAM A 400 (-3.8A) SAM A 400 (-2.9A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.50A	2okcB-2f8lA: 25.2	2okcB-2f8lA: 24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_2 (ESTROGEN RECEPTOR)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 5	LEU A 123 ASP A 191 MET A 174 LEU A 176	None	1.21A	2qxsA-2f8lA: undetectable	2qxsA-2f8lA: 22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_B_RALB600_2 (ESTROGEN RECEPTOR)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 5	LEU A 123 ASP A 191 MET A 174 LEU A 176	None	1.22A	2qxsB-2f8lA: undetectable	2qxsB-2f8lA: 22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UYQ_A_SAMA1311_0 (HYPOTHETICAL PROTEIN ML2640)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 7	ALA A 126 GLY A 128 ASP A 154 ASP A 180	SAM A 400 (-3.4A) SAM A 400 (-3.3A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.75A	2uyqA-2f8lA: 9.9	2uyqA-2f8lA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XKW_A_P1BA1478_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 7	LEU A 308 ILE A 105 GLN A 139 ILE A 122	None	0.83A	2xkwA-2f8lA: undetectable	2xkwA-2f8lA: 22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7H_B_SAMB530_0 (TYPE I RESTRICTION ENZYME ECOKI M PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	7 / 12	THR A 98 ALA A 126 GLY A 128 THR A 129 LEU A 182 PRO A 198 PHE A 226	SAM A 400 (-3.8A) SAM A 400 (-3.4A) SAM A 400 (-3.3A) SAM A 400 (-2.9A) SAM A 400 ( 4.8A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	0.91A	2y7hB-2f8lA: 23.3	2y7hB-2f8lA: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7H_C_SAMC530_0 (TYPE I RESTRICTION ENZYME ECOKI M PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	7 / 12	THR A 98 ALA A 126 GLY A 128 THR A 129 LEU A 182 PRO A 198 PHE A 226	SAM A 400 (-3.8A) SAM A 400 (-3.4A) SAM A 400 (-3.3A) SAM A 400 (-2.9A) SAM A 400 ( 4.8A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	0.91A	2y7hC-2f8lA: 23.4	2y7hC-2f8lA: 22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DOU_A_SAMA1_1 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	3 / 3	ASP A 154 ASP A 180 ASP A 196	SAM A 400 (-2.7A) SAM A 400 (-3.4A) SAM A 400 (-3.7A)	0.60A	3douA-2f8lA: 10.6	3douA-2f8lA: 18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHX_B_PXLB313_1 (PYRIDOXAL KINASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 8	SER A 195 VAL A 193 PHE A 226 VAL A 190	None None SAM A 400 (-4.9A) None	0.99A	3fhxB-2f8lA: 2.7	3fhxB-2f8lA: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FZG_A_SAMA300_0 (16S RRNA METHYLASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	HIS A 266 GLY A 238 LEU A 240 VAL A 113 GLN A 115	GOL A 401 ( 4.7A) None None None None	1.29A	3fzgA-2f8lA: 9.5	3fzgA-2f8lA: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OU7_C_SAMC300_1 (SAM-DEPENDENT METHYLTRANSFERASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	3 / 3	GLY A 128 ASP A 154 ASP A 180	SAM A 400 (-3.3A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.47A	3ou7C-2f8lA: 9.9	3ou7C-2f8lA: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 11	GLY A 128 ASP A 154 ASP A 156 ASP A 180 PRO A 198	SAM A 400 (-3.3A) SAM A 400 (-2.7A) None SAM A 400 (-3.4A) SAM A 400 (-3.8A)	0.56A	3v8vB-2f8lA: 10.3	3v8vB-2f8lA: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJJ_A_NCTA501_1 (CYTOCHROME P450 2A6)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 7	PHE A 241 PHE A 328 GLY A 269 ILE A 324	None GOL A 401 (-4.9A) None None	0.81A	4ejjA-2f8lA: undetectable	4ejjA-2f8lA: 23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_A_DGXA1107_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	ASP A 124 LEU A 123 GLY A 181 PHE A 226 LEU A 197	SAM A 400 ( 4.8A) None SAM A 400 (-3.6A) SAM A 400 (-4.9A) None	1.05A	4retA-2f8lA: undetectable	4retA-2f8lA: 18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RET_C_DGXC2005_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	ASP A 124 LEU A 123 GLY A 181 PHE A 226 LEU A 197	SAM A 400 ( 4.8A) None SAM A 400 (-3.6A) SAM A 400 (-4.9A) None	1.05A	4retC-2f8lA: 2.6	4retC-2f8lA: 18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTB_A_SAMA501_0 (HYDG PROTEIN)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	TYR A 233 ASN A 207 LEU A 185 LEU A 123 PHE A 226	None None None None SAM A 400 (-4.9A)	1.32A	4rtbA-2f8lA: undetectable	4rtbA-2f8lA: 24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E72_A_SAMA400_1 (N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	4 / 4	ASP A 124 GLY A 128 ASP A 154 ASP A 180	SAM A 400 ( 4.8A) SAM A 400 (-3.3A) SAM A 400 (-2.7A) SAM A 400 (-3.4A)	0.43A	5e72A-2f8lA: 15.9	5e72A-2f8lA: 24.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IEN_A_VDYA201_1 (CDL2.2)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	LEU A 243 ILE A 271 THR A 135 ALA A 107 LEU A 109	None	1.21A	5ienA-2f8lA: undetectable	5ienA-2f8lA: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_B_8LXB501_0 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	LEU A 308 ILE A 105 GLN A 139 ILE A 114 ILE A 324	None	0.94A	5y2tB-2f8lA: undetectable	5y2tB-2f8lA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_A_SAMA601_0 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	5 / 12	ALA A 126 GLY A 128 THR A 129 LEU A 182 PHE A 226	SAM A 400 (-3.4A) SAM A 400 (-3.3A) SAM A 400 (-2.9A) SAM A 400 ( 4.8A) SAM A 400 (-4.9A)	0.74A	5ybbA-2f8lA: 25.2	5ybbA-2f8lA: 22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_B_SAMB601_0 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	2f8l	HYPOTHETICAL PROTEIN LMO1582 (Listeria monocytogenes)	6 / 12	THR A 98 ASP A 124 THR A 129 LEU A 182 PRO A 198 PHE A 226	SAM A 400 (-3.8A) SAM A 400 ( 4.8A) SAM A 400 (-2.9A) SAM A 400 ( 4.8A) SAM A 400 (-3.8A) SAM A 400 (-4.9A)	0.66A	5ybbB-2f8lA: 25.3	5ybbB-2f8lA: 22.13

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D4Y_A_TPVA501_2","PROTEIN (HIV-1 PROTEASE);PROTEIN (HIV-1 PROTEASE)","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"LEU A 321;ALA A 306;GLY A 269;ILE A 289;ILE A 320","None","1.49A","1d4yB-2f8lA:undetectable","1d4yB-2f8lA:14.66"],["1ERR_B_RALB600_2","ESTROGEN RECEPTOR","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"LEU A 123;ASP A 191;MET A 174;LEU A 176","None","1.18A","1errB-2f8lA:undetectable","1errB-2f8lA:22.97"],["1HK2_A_T44A3004_1","SERUM ALBUMIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"PHE A 249;ALA A 306;LEU A 305;VAL A 303","None","0.93A","1hk2A-2f8lA:undetectable","1hk2A-2f8lA:19.63"],["1QAO_A_SAMA245_0","ERMC' METHYLTRANSFERASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"GLY A 128;ASP A 156;LEU A 159;ASP A 180;PRO A 198","SAM A 400 (-3.3A);None;SAM A 400 (-4.3A);SAM A 400 (-3.4A);SAM A 400 (-3.8A)","0.70A","1qaoA-2f8lA:12.4","1qaoA-2f8lA:22.54"],["1SQF_A_SAMA430_1","SUN PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",3,"PRO A 125;ASP A 154;ASP A 180","None;SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.78A","1sqfA-2f8lA:11.8","1sqfA-2f8lA:22.40"],["2ADM_A_SAMA500_0","ADENINE-N6-DNA-METHYLTRANSFERASE TAQI","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"ALA A 126;ASP A 156;ASP A 180;PRO A 198;PHE A 226","SAM A 400 (-3.4A);None;SAM A 400 (-3.4A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","0.59A","2admA-2f8lA:19.9","2admA-2f8lA:21.87"],["2ADM_A_SAMA500_0","ADENINE-N6-DNA-METHYLTRANSFERASE TAQI","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"THR A  98;ALA A 126;ASP A 180;PRO A 198;PHE A 226","SAM A 400 (-3.8A);SAM A 400 (-3.4A);SAM A 400 (-3.4A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","1.06A","2admA-2f8lA:19.9","2admA-2f8lA:21.87"],["2ADM_B_SAMB500_0","ADENINE-N6-DNA-METHYLTRANSFERASE TAQI","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"THR A  98;ALA A 126;ASP A 180;PRO A 198;PHE A 226","SAM A 400 (-3.8A);SAM A 400 (-3.4A);SAM A 400 (-3.4A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","1.07A","2admB-2f8lA:20.0","2admB-2f8lA:21.87"],["2AOU_B_CQAB401_0","HISTAMINE N-METHYLTRANSFERASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"GLY A 181;ASP A 204;TYR A 202;THR A 210","SAM A 400 (-3.6A);None;None;None","1.13A","2aouB-2f8lA:13.2","2aouB-2f8lA:23.24"],["2CDQ_A_SAMA1500_0","ASPARTOKINASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"ILE A 122;SER A 121;ASP A 191;LEU A 110","None","0.95A","2cdqA-2f8lA:undetectable","2cdqA-2f8lA:22.74"],["2F8L_A_SAMA400_0","HYPOTHETICAL PROTEIN LMO1582","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",12,"HIS A  95;ALA A 126;GLY A 128;ASN A 131;LEU A 132;VAL A 155;ASP A 156;LEU A 159;GLY A 181;ASP A 196;PRO A 198;PHE A 226","SAM A 400 (-4.5A);SAM A 400 (-3.4A);SAM A 400 (-3.3A);None;SAM A 400 (-4.1A);SAM A 400 (-4.2A);None;SAM A 400 (-4.3A);SAM A 400 (-3.6A);SAM A 400 (-3.7A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","0.04A","2f8lA-2f8lA:56.4","2f8lA-2f8lA:100.00"],["2F8L_A_SAMA400_0","HYPOTHETICAL PROTEIN LMO1582","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",8,"HIS A  95;ALA A 126;GLY A 128;LEU A 133;VAL A 155;ASP A 156;LEU A 159;PHE A 226","SAM A 400 (-4.5A);SAM A 400 (-3.4A);SAM A 400 (-3.3A);None;SAM A 400 (-4.2A);None;SAM A 400 (-4.3A);SAM A 400 (-4.9A)","1.43A","2f8lA-2f8lA:56.4","2f8lA-2f8lA:100.00"],["2F8L_A_SAMA400_1","HYPOTHETICAL PROTEIN LMO1582","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"THR A  98;THR A 129;ASP A 154;ASP A 180","SAM A 400 (-3.8A);SAM A 400 (-2.9A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.03A","2f8lA-2f8lA:56.4","2f8lA-2f8lA:100.00"],["2OKC_A_SAMA500_1","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"THR A  98;THR A 129;ASP A 154;ASP A 180","SAM A 400 (-3.8A);SAM A 400 (-2.9A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.41A","2okcA-2f8lA:25.5","2okcA-2f8lA:24.57"],["2OKC_B_SAMB500_1","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"THR A  98;THR A 129;ASP A 154;ASP A 180","SAM A 400 (-3.8A);SAM A 400 (-2.9A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.50A","2okcB-2f8lA:25.2","2okcB-2f8lA:24.57"],["2QXS_A_RALA600_2","ESTROGEN RECEPTOR","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"LEU A 123;ASP A 191;MET A 174;LEU A 176","None","1.21A","2qxsA-2f8lA:undetectable","2qxsA-2f8lA:22.55"],["2QXS_B_RALB600_2","ESTROGEN RECEPTOR","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"LEU A 123;ASP A 191;MET A 174;LEU A 176","None","1.22A","2qxsB-2f8lA:undetectable","2qxsB-2f8lA:22.55"],["2UYQ_A_SAMA1311_0","HYPOTHETICAL PROTEIN ML2640","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"ALA A 126;GLY A 128;ASP A 154;ASP A 180","SAM A 400 (-3.4A);SAM A 400 (-3.3A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.75A","2uyqA-2f8lA:9.9","2uyqA-2f8lA:21.88"],["2XKW_A_P1BA1478_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"LEU A 308;ILE A 105;GLN A 139;ILE A 122","None","0.83A","2xkwA-2f8lA:undetectable","2xkwA-2f8lA:22.13"],["2Y7H_B_SAMB530_0","TYPE I RESTRICTION ENZYME ECOKI M PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",7,"THR A  98;ALA A 126;GLY A 128;THR A 129;LEU A 182;PRO A 198;PHE A 226","SAM A 400 (-3.8A);SAM A 400 (-3.4A);SAM A 400 (-3.3A);SAM A 400 (-2.9A);SAM A 400 ( 4.8A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","0.91A","2y7hB-2f8lA:23.3","2y7hB-2f8lA:22.71"],["2Y7H_C_SAMC530_0","TYPE I RESTRICTION ENZYME ECOKI M PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",7,"THR A  98;ALA A 126;GLY A 128;THR A 129;LEU A 182;PRO A 198;PHE A 226","SAM A 400 (-3.8A);SAM A 400 (-3.4A);SAM A 400 (-3.3A);SAM A 400 (-2.9A);SAM A 400 ( 4.8A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","0.91A","2y7hC-2f8lA:23.4","2y7hC-2f8lA:22.71"],["3DOU_A_SAMA1_1","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",3,"ASP A 154;ASP A 180;ASP A 196","SAM A 400 (-2.7A);SAM A 400 (-3.4A);SAM A 400 (-3.7A)","0.60A","3douA-2f8lA:10.6","3douA-2f8lA:18.73"],["3FHX_B_PXLB313_1","PYRIDOXAL KINASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"SER A 195;VAL A 193;PHE A 226;VAL A 190","None;None;SAM A 400 (-4.9A);None","0.99A","3fhxB-2f8lA:2.7","3fhxB-2f8lA:22.63"],["3FZG_A_SAMA300_0","16S RRNA METHYLASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"HIS A 266;GLY A 238;LEU A 240;VAL A 113;GLN A 115","GOL A 401 ( 4.7A);None;None;None;None","1.29A","3fzgA-2f8lA:9.5","3fzgA-2f8lA:21.84"],["3OU7_C_SAMC300_1","SAM-DEPENDENT METHYLTRANSFERASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",3,"GLY A 128;ASP A 154;ASP A 180","SAM A 400 (-3.3A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.47A","3ou7C-2f8lA:9.9","3ou7C-2f8lA:18.68"],["3V8V_B_SAMB801_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"GLY A 128;ASP A 154;ASP A 156;ASP A 180;PRO A 198","SAM A 400 (-3.3A);SAM A 400 (-2.7A);None;SAM A 400 (-3.4A);SAM A 400 (-3.8A)","0.56A","3v8vB-2f8lA:10.3","3v8vB-2f8lA:20.06"],["4EJJ_A_NCTA501_1","CYTOCHROME P450 2A6","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"PHE A 241;PHE A 328;GLY A 269;ILE A 324","None;GOL A 401 (-4.9A);None;None","0.81A","4ejjA-2f8lA:undetectable","4ejjA-2f8lA:23.13"],["4RET_A_DGXA1107_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"ASP A 124;LEU A 123;GLY A 181;PHE A 226;LEU A 197","SAM A 400 ( 4.8A);None;SAM A 400 (-3.6A);SAM A 400 (-4.9A);None","1.05A","4retA-2f8lA:undetectable","4retA-2f8lA:18.30"],["4RET_C_DGXC2005_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"ASP A 124;LEU A 123;GLY A 181;PHE A 226;LEU A 197","SAM A 400 ( 4.8A);None;SAM A 400 (-3.6A);SAM A 400 (-4.9A);None","1.05A","4retC-2f8lA:2.6","4retC-2f8lA:18.30"],["4RTB_A_SAMA501_0","HYDG PROTEIN","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"TYR A 233;ASN A 207;LEU A 185;LEU A 123;PHE A 226","None;None;None;None;SAM A 400 (-4.9A)","1.32A","4rtbA-2f8lA:undetectable","4rtbA-2f8lA:24.23"],["5E72_A_SAMA400_1","N2, N2-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",4,"ASP A 124;GLY A 128;ASP A 154;ASP A 180","SAM A 400 ( 4.8A);SAM A 400 (-3.3A);SAM A 400 (-2.7A);SAM A 400 (-3.4A)","0.43A","5e72A-2f8lA:15.9","5e72A-2f8lA:24.50"],["5IEN_A_VDYA201_1","CDL2.2","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"LEU A 243;ILE A 271;THR A 135;ALA A 107;LEU A 109","None","1.21A","5ienA-2f8lA:undetectable","5ienA-2f8lA:17.78"],["5Y2T_B_8LXB501_0","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"LEU A 308;ILE A 105;GLN A 139;ILE A 114;ILE A 324","None","0.94A","5y2tB-2f8lA:undetectable","5y2tB-2f8lA:undetectable"],["5YBB_A_SAMA601_0","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",5,"ALA A 126;GLY A 128;THR A 129;LEU A 182;PHE A 226","SAM A 400 (-3.4A);SAM A 400 (-3.3A);SAM A 400 (-2.9A);SAM A 400 ( 4.8A);SAM A 400 (-4.9A)","0.74A","5ybbA-2f8lA:25.2","5ybbA-2f8lA:22.13"],["5YBB_B_SAMB601_0","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","2f8l","HYPOTHETICAL PROTEIN LMO1582","Listeria monocytogenes",6,"THR A  98;ASP A 124;THR A 129;LEU A 182;PRO A 198;PHE A 226","SAM A 400 (-3.8A);SAM A 400 ( 4.8A);SAM A 400 (-2.9A);SAM A 400 ( 4.8A);SAM A 400 (-3.8A);SAM A 400 (-4.9A)","0.66A","5ybbB-2f8lA:25.3","5ybbB-2f8lA:22.13"]]